Categories
Business

O.E.C.D. Raises International Progress Forecast Sharply, Citing Vaccines

The global economy is expected to recover from the coronavirus pandemic faster than expected this year, as vaccinations in advanced economies and an enormous fiscal stimulus package in the United States unleash pent-up business activity and job creation, the Organization for Economic Cooperation and Development said on Monday.

But the pace of the recovery still hinges on vaccination programs and the ability of governments to beat back new variants of the virus, raising fresh risks even as economic activity starts to rev back up in most parts of the world, the organization said in its latest economic outlook.

The organization sharply raised its forecast for global growth to 5.8 percent in 2021, up from a 4.2 percent projection in December. It said the pace of expansion would cool to 4.5 percent in 2022 as government support programs unwind.

A government stimulus-led upturn in the United States, where President Biden is betting on a $2 trillion infrastructure package to end the effects of the pandemic faster, has helped improve the global outlook, the group said. China continues to experience the world’s strongest rebound, also lifting the global outlook.

In Europe, which has been lagging the United States in a recovery, an acceleration of vaccination programs has allowed governments to begin lifting restrictions on activities, speeding up what had been a slow economic reopening.

The opposite is true for many emerging-market economies that are suffering from slow distribution of vaccines, new outbreaks of Covid-19 and economically limiting containment measures, dampening prospects for a quick recovery.

India, which has suffered a deadly resurgence of the virus, is likely to face economic struggles as a result and a slower return to prepandemic growth levels until the impact of the virus fades, the organization said.

It estimated the economy in the United States would grow 6.9 percent in 2021; in China, 8.5 percent; in the euro area, 4.3 percent; in Britain, 7.2 percent; in Argentina, 6.1 percent; and in India, 9.9 percent.

“Our latest projections provide hope that in many countries, people hit hard by the pandemic may soon be able to return to work and start living a normal life again,” Laurence Boone, the organization’s chief economist, said during a news briefing.

“But we are at a critical stage of the recovery. Vaccination production and distribution have to accelerate globally and be backed by effective public health strategies,” she said.

Categories
Health

Russia Covid vaccines will not be obligatory Putin says amid skepticism

Russian President Vladimir Putin examines military aircraft flying over the Kremlin and Red Square to celebrate the 75th anniversary of the victory over Nazi Germany in World War II in Moscow on May 9, 2020.

Alexey Druzhinin | AFP | Getty Images

President Vladimir Putin ruled Russia will not make Covid vaccines mandatory for its citizens, saying people should see the need to vaccinate for themselves.

Some officials in Russia had suggested making vaccination compulsory, but Putin said Wednesday that such a move would be “counterproductive”.

During a video conference on the economy, Putin said officials had analyzed options, including compulsory vaccination for the entire population or for workers in specific sectors who come into contact with large numbers of people, Russian news agency Tass reported.

This could have made Covid recordings mandatory for people who work in areas such as retail, education, or transportation. Putin said he did not approve of such a move.

“In my opinion, it is counterproductive and unnecessary to introduce compulsory vaccinations,” he said. “People should recognize this need for themselves” and understand that without a vaccine they “may be at very serious and even fatal danger”, especially the elderly.

Putin urged the public to get vaccinated, stressing that Russian Sputnik V vaccine is safe.

“I want to emphasize again and address all of our citizens: think carefully, remember that the Russian vaccine – practice has already shown that millions (of people) have used it – is currently the most reliable and safest,” said Putin. “All the conditions for vaccination have been created in our country.”

Vaccine hesitate

Despite the pleas from the President and other senior officials and the establishment of walk-in vaccination centers in shopping malls in major cities, Russia has found that much of its population is unwilling to receive a Covid shot.

Some officials have tried more unusual means of persuading those who hesitate. Moscow is offering free ice cream to everyone who has been vaccinated in Red Square and buying vouchers or gift cards worth 1,000 rubles (about $ 13.60) for retirees. Some Russian regions have reportedly offered cash incentives to get the shot.

Moscow Mayor Sergei Sobyanin has openly expressed his frustration at the slow response to vaccinations.

“It’s remarkable … people get sick, they keep getting sick, they keep dying. And yet they don’t want to get vaccinated,” Sobyanin said in comments posted on a video blog on Friday and reported by Reuters.

“We were the first big city in the world to announce the start of mass vaccination. And what?” Sobyanin said. “The percentage of people vaccinated in Moscow is lower than in any European city. In some cases, many times over.”

He noted that so far only 1.3 million people in Moscow had received a shot from a population of 12 million.

As of Wednesday, just over 11% of the Russian population had received at least one dose of a coronavirus vaccine, according to Our World In Data. This is comparable to the rate in India, which has also struggled to get its vaccination program off the ground due to production problems, but is lagging behind other major economies. For example, the UK has given at least one dose to over 70% of its population.

The home of Sputnik V.

That frustration is more palpable in Russia because it was one of the first countries in the world to approve a Covid vaccine last August. Initially, there were concerns about the safety and efficacy data of Sputnik V, particularly when Russia approved the shot prior to the completion of clinical trials, which aroused suspicion in the international scientific community.

However, the Sputnik V vaccine was found to be 91.6% effective in preventing people from developing Covid-19. This is evident from the peer-reviewed results of its late-stage clinical study published in The Lancet Medical Journal in February.

Even so, a poll published in March by Russian polling station Levada found that 62% of people did not want to receive the vaccine, with 18- to 24-year-olds showing the greatest reluctance.

Categories
Health

Two doses of Covid vaccines present safety in opposition to India variant

A healthcare worker holds syringes with the Moderna and Pfizer vaccines against the coronavirus disease (COVID-19) at a vaccination centre, in El Paso, Texas, May 6, 2021.

Jose Luis Gonzalez | Reuters

A new study has found that two doses of either the Pfizer-BioNTech or AstraZeneca-University of Oxford vaccine give effective protection against the Covid variant first discovered in India, however it underscored the need for two doses, as both vaccines were significantly less effective after only one shot.

The study, led by Public Health England, also found that two doses of one of those vaccines were similarly as effective at protecting against the variant that first emerged in the U.K. and has since become a dominant strain in the West.

Dr. Jenny Harries, CEO of the U.K. Health Security Agency, told the BBC that the study provided the “first real-world evidence of vaccine effectiveness” against the variant first identified in India.

Conducted between April and May, the research found that the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617.2 Covid variant — a subtype of a variant that emerged in India last fall which has since spread to Europe — two weeks after the second dose. The vaccine was 93% effective two weeks after the second dose against the B.1.1.7 variant. which was first discovered in the U.K. last fall.

Meanwhile, two doses of the AstraZeneca vaccine were found to be 60% effective against symptomatic disease from the B.1.617.2 variant from India, compared with 66% effective against the strain from the U.K.

“Vaccine effectiveness against symptomatic disease from the B.1.617.2 variant is similar after 2 doses compared to the B.1.1.7 (Kent) variant dominant in the U.K., and we expect to see even higher levels of effectiveness against hospitalisation and death,” the study authors wrote. The results were published Saturday as a preprint and the study has not yet been peer-reviewed.

PHE said the difference in effectiveness between the vaccines after two doses “may be explained by the fact that rollout of second doses of AstraZeneca was later than for the Pfizer-BioNTech vaccine, and other data on antibody profiles show it takes longer to reach maximum effectiveness with the AstraZeneca vaccine.”

However, both vaccines were only 33% effective against symptomatic disease from B.1.617.2 three weeks after the first dose. In the same time frame, they were found to be 50% effective against the B.1.1.7 variant.

Variant of concern

The variant first discovered in India has been blamed for causing a dramatic third wave of infections in the country, overwhelming hospitals and causing thousands of deaths this spring. There were concerns that Covid vaccines could be rendered less effective by the variant so the latest data should help allay those worries.

The India variant has been detected in numerous other countries now, according to the World Health Organization, which dubbed it a “variant of concern” in early May.

The PHE study analyzed data from 1,054 people, of all age groups and several ethnicities, confirmed as having the B.1.617.2 variant through genomic sequencing. The data was collected from April 5 and hence covers the period since the B.1.617.2 variant (one of three variant subtypes found in India) emerged in parts of the U.K.

“As with other variants, even higher levels of effectiveness are expected against hospitalisation and death. There are currently insufficient cases and follow-up periods to estimate vaccine effectiveness against severe outcomes from the B.1.617.2 variant. PHE will continue to evaluate this over the coming weeks,” the study’s authors added.

Responding to the study, the U.K.’s health secretary, Matt Hancock, described the findings as “groundbreaking – and proves just how valuable our Covid-19 vaccination programme is in protecting the people we love.”

The U.K. has given more than 22 million people two doses of a Covid vaccine, while 72% of the population (or almost 40 million people) have had one shot, government data shows.

Hancock said the latest data emphasized “how important the second dose is to secure the strongest possible protection” against Covid-19 and its variants.

Separate PHE analysis indicated that the country’s Covid-19 vaccination program has so far prevented 13,000 deaths and around 39,100 hospitalizations in older people in England, up to May 9.

Categories
Health

Olympic organizers ought to mandate Covid vaccines for athletes and followers at Tokyo Video games

Arthur L. Caplan is the founding head of the Division of Medical Ethics at NYU School of Medicine in New York City and Lee H. Igel is a clinical professor in the NYU Tisch Institute for Global Sport.

Pfizer and BioNTech are donating doses of their Covid-19 vaccine to athletes and delegations heading for the Tokyo Olympic and Paralympic Games this July.

With so many people around the world still waiting for a jab and the pandemic not letting up in more than a few regions, should Olympians be jumping the vaccine line? Yes — and they ought to get a running start with a tough, mandatory program as soon as possible.

The offer to donate the doses came up during a recent conversation that Pfizer CEO Albert Bourla was having with Japanese Prime Minister Suga Yoshihide. That led that Japanese government into discussing the opportunity in a meeting with the International Olympic Committee. The IOC then worked with Pfizer and BioNTech on a memorandum of understanding. It will have National Olympic Committees across the globe — 206 in all — coordinate with their local governments to administer vaccinations to athletes and delegates who are eligible for them.  Given the two-shot schedule, they need to start now.

Japan is planning to host a total of about 15,000 athletes at the Olympic and Paralympic Games. Several thousand more people who will travel as part of the delegations will join them, even as numbers are limited due to pandemic regulations. Some of those heading to Tokyo will have been vaccinated already. Many, however, will have not yet had access to a vaccine. Others will have refused to take it because they are hesitant or don’t believe in its safety.

How many thousands of doses will end up being provided to the Olympic movement remains to be seen. Pfizer, BioNTech, and the IOC have said that those doses will be in addition to amounts already set to be supplied to different countries. But many people are wondering, if the pharmaceutical firms can produce extra vaccines for Olympic allotment, shouldn’t those doses go to people who are at greater risk for severe illness or death if they contract Covid?  

 That is a fair question, but it misses an important reality: the Games are on pace to take place as scheduled. This despite the fact that Tokyo and surrounding prefectures are under a government-mandated state of emergency because of high Covid infection rates.  But Japan is too far down the road to cancel the Games, which were already postponed once.

At a cost of more than $26 billion, the coming version of the Tokyo Olympics is the most expensive Summer Games ever. True, a majority of the Japanese public — about 60%, according to Yomiuri Shimbun polling, and up to 80%, according to polls cited by the Associated Press — opposes holding the Games. Doctors and nurses are protesting, and employees in at least one hospital posted signs in windows pleading for the Games to be canceled, because of overcapacity. But the money invested, not public health concerns, are now driving events. Unless a shock catastrophic event takes place, the Games will go on.

The Olympic festival, its athletes and delegates, and registered media and broadcast teams will be flowing into and around into Japan in late July. Even if Tokyo reduces the infection rate to a more manageable level in time for opening ceremonies, allowing thousands of unvaccinated people to enter and move about is irresponsible. It risks real strain on health care and public safety systems in the Olympic venues and throughout the city, in a nation that has one of the highest rates of vaccine hesitancy and lowest rates of vaccine confidence in the world.

The IOC will not be requiring athletes and delegates to have received a vaccine in order to participate in the Games. That is flat out wrong, given the danger of spreading new strains around the world when participants return home from the Games. Athletes, coaches, delegates, media, and suppliers, should be required to take the two-shot vaccine doses being offered. There is a need to keep as many people as safe as possible, and vaccines can help greatly in that regard.

Authentication by a physician that a person has been vaccinated a minimum of one month before the Games should be part of the protocol. So should frequent testing just prior to departure, on arrival, and throughout the Games, as should maintaining a tight bubble at all Olympic sites, venues and lodgings.

Olympic athletes and their support staff can be seen as “essential workers,” in that their participation in the Games can be seen by the world as a sign of good things happening in a bleak time. As IOC President Thomas Bach said, they can “lead by example … and send a powerful message that vaccination is not only about personal health, but also about solidarity and consideration of the wellbeing of others in their communities.”

Arguing about canceling the Games is over. They are going to happen. The organizers and athletes have about a month from now to insure their safety, the safety of Tokyo, and the safety of the world. Vaccination, testing, and quarantine are the key tools to aligning public health with the world’s desire for a bit of relief from a deadly plague. Let’s hope the IOC, local organizing committee and Japan get this right.

Categories
Business

Vaccines not the one issue driving Covid circumstances down

More Americans are being vaccinated against Covid every day, but that’s not the only reason coronavirus cases continue to decline in the US, said Dr. Scott Gottlieb told CNBC on Friday.

In an interview on Closing Bell, the former Commissioner of the Food and Drug Administration said that additional factors contributing to a drop in infection rates are the warming weather and the fact that part of the unvaccinated population has already been infected with Covid .

Gottlieb’s comments came Friday when the country’s seven-day average of new daily coronavirus infections fell below 30,000 for the first time in nearly a year. At the end of March there were around 66,000.

The decline in cases coincided with an increase in the availability of vaccines. As of Friday, nearly 50% of the U.S. population had received at least one dose of Covid vaccine, according to the Centers for Disease Control and Prevention. At the end of March that number was a little less than 30%.

However, the percentage of Americans who have some immunity to coronavirus is higher than vaccination rates, Gottlieb said, estimating that at least a third of the population is infected. The US had around 33 million confirmed Covid cases in total, but Gottlieb has repeatedly said the official record is an undercount.

“We don’t have any data on this, but I suspect that the level of infection is likely higher in the unvaccinated population because many people are likely not getting the vaccine because they knew they were previously infected,” said Gottlieb.

People who have recovered from Covid have natural antibodies, but the CDC and other experts recommend that they get the vaccine too. In fact, people who have had the disease and received the Covid shot may develop stronger protection against variants of the virus.

People who have not yet been vaccinated may have been less concerned about the virus during the pandemic and therefore spent less time at home, Gottlieb added.

So if you assume that the percentage of previous infections in the unvaccinated population is more than one third, and it probably is, and you assume that we have currently given at least one dose to about half the population “We’re getting closer to a pretty high level of immunity,” said Gottlieb, who headed the FDA in the Trump administration from 2017 to 2019. Today he is a board member of the vaccine manufacturer Pfizer.

And while states are lifting many pandemic-time restrictions such as: B. Restaurant capacity constraints, some people have not reverted to their pre-Covid behavior, which helps reduce cases.

“People are generally more cautious, although we are starting to take off masks and be on the move,” said Gottlieb. “People are more careful about their interactions, so some of it still has a downward impact on transmission.”

Gottlieb predicted the country’s case numbers will continue to decline in the coming weeks, while the pandemic is unlikely to be classified as “ended”. He added, “I think we will have a very calm summer in terms of the coronavirus spread and then have to deal with it again when we start into winter.”

Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, healthcare technology company Aetion, and Illumina biotech. He is also co-chair of the Healthy Sail Panel for Norwegian Cruise Line Holdings and Royal Caribbean.

Categories
World News

Covid-19 Information: Stay Updates on Circumstances and Vaccines

Here’s what you need to know:

Credit…Mario Tama/Getty Images

GENEVA — Deaths from Covid-19 and Covid-related causes are likely to be two to three times the number that countries have recorded in their official data, the World Health Organization said on Friday.

Some six to eight million people may have now died from Covid-19 or its effects since the start of the pandemic, compared with 3.4 million deaths recorded in countries’ official reporting, Dr. Samira Asma, assistant director of the W.H.O.’s data division, told reporters.

The W.H.O. also estimates that at least three million people may have died from Covid-19 in 2020, compared with 1.8 million recorded in official data, the W.H.O. reported in annual statistics released on Friday.

The W.H.O. based its assessment on a statistical model that estimates the excess deaths attributable to Covid-19. The technique involves taking the total number of officially recorded deaths and then subtracting the number of deaths that would have been expected on the basis of previous mortality trends if the pandemic had not occurred.

On that basis, the W.H.O. said it estimated that 1.1 million to 1.3 million people in 53 European countries died from Covid-19 in 2020, roughly double the number recorded in official data. The organization also calculates that, over the same period, 1.3 million to 1.5 million people died in 35 countries in the Americas, compared with the 900,000 deaths officially recorded.

The huge discrepancy between the W.H.O.’s estimates and official data underscores the limited capacity of many countries to test their populations for the coronavirus and other weaknesses in official health data. For example, some Covid victims had died before being tested and their deaths did not appear in official reporting, William Msemburi, a W.H.O. data analyst said.

The W.H.O. will present its statistics to the annual meeting of its policymaking assembly in Geneva next week. The numbers will help make the case for countries to invest urgently in bolstering data systems and their capacity to monitor and report health developments.

“We can only be better prepared with better data,” Dr. Asma said.

United States › United StatesOn May 20 14-day change
New cases 29,701 –36%
New deaths 654 –14%
World › WorldOn May 20 14-day change
New cases 636,014 –23%
New deaths 12,828 –6%

U.S. vaccinations ›

Where states are reporting vaccines given

Moving a Covid-19 patient at Kenyatta National Hospital in Nairobi, Kenya, in April. Just 1.42 percent of the population of Africa has been fully vaccinated.Credit…Brian Inganga/Associated Press

When the pandemic began, global health officials feared that the vulnerabilities of Africa would lead to devastation. More than a year later, the rates of illness and death from Covid in Africa appear to be lower than in the rest of the world, upending scientists’ expectations.

But if the virus begins to spread more rapidly on the continent, as it has in other regions, new findings suggest that the death toll could worsen.

People in Africa who become critically ill from Covid-19 are more likely to die than patients in other parts of the world, according to a report published on Thursday in the medical journal The Lancet.

The report, based on data from 64 hospitals in 10 countries, is the first broad look at what happens to critically ill Covid patients in Africa, the authors say. The increased risk of death applies only to those who become severely ill.

Among 3,077 critically ill patients admitted to the African hospitals, 48.2 percent died within 30 days, compared with a global average of 31.5 percent, the Lancet study found.

The study was observational, meaning that the researchers followed the patients’ progress, but did not experiment with treatments.

For Africa as a whole, the death rate among severely ill Covid patients may be even higher than it was in the study, the researchers said, because much of their information came from relatively well-equipped hospitals, and 36 percent of those facilities were in South Africa and Egypt, which have better resources than many other African countries. In addition, the patients in the study, with an average age of 56, were younger than many other critically ill Covid patients, indicating that death rates outside the study could be higher.

Reliable data on a country’s deaths and their causes have been hard to come by. As the coronavirus pandemic swept across the world in 2020, it has became increasingly evident that in a majority of countries on the African continent, most deaths are never formally registered.

The other eight countries in the study were Ethiopia, Ghana, Kenya, Libya, Malawi, Mozambique, Niger and Nigeria. Leaders of 16 other African nations had also agreed to participate, but ultimately did not.

Reasons for the higher death rates include a lack of resources such as surge capacity in intensive care units, equipment to measure patients’ oxygen levels, dialysis machines and so-called ECMO devices to pump oxygen into the bloodstream of patients whose lungs become so impaired that even a ventilator is not enough to keep them alive.

But there was also an apparent failure to use resources that were available, the authors of the study suggested. Proning — turning patients onto their stomachs to help them breathe — was underused, performed for only about a sixth of the patients who needed it.

The slow introduction of vaccines across the continent has underscored global problems of vaccine inequality. Just over 24 million vaccines have been administered in Africa, according to the Africa C.D.C., with just 1.42 percent of the population fully vaccinated. In the United States, about 126.6 million people are fully vaccinated and more than 60 percent of adults have received at least one shot.

Facing a resurgent coronavirus and plagued by delays with vaccine supply, South Africa began the second phase of its public vaccination campaign on Monday, opening appointments for people aged 60 or older. The country has a 14.5 percent positivity rate, according to the Africa C.D.C.

Signing up for vaccinations in Kochi, Japan, last month.Credit…Kyodo News, via Associated Press

Japan on Friday approved the Moderna and AstraZeneca coronavirus vaccines for use in adults, giving the country much-needed new options as it tries to speed up an inoculation campaign that has been one of the slowest in the developed world.

Previously, only the Pfizer vaccine had been authorized for use in Japan, where just 4.1 percent of the population has received a first shot. Vaccinations have been held up by strict rules that allow only doctors and nurses to administer shots, and by a requirement that vaccines be tested on people in Japan before they are approved for use.

Japan is in the midst of a fourth wave of coronavirus infections, just two months before the Summer Olympics in Tokyo are set to begin. Tokyo and eight other prefectures are under a state of emergency that will last at least until the end of this month, and Okinawa is expected to be added to that list. Japan has been reporting about 5,500 cases a day, compared to 1,000 in early March.

A Health Ministry panel recommended on Thursday night that the government approve the Moderna and AstraZeneca vaccines. The health minister, Norihisa Tamura, said that the Moderna shots would be used at mass inoculation sites scheduled to open on Monday in Tokyo and Osaka, which will be staffed mainly by military doctors and nurses.

The government has not said when the AstraZeneca vaccine would be deployed. NHK, the public broadcaster, reported that despite the green light from the government, the use of AstraZeneca might be delayed over concerns that it could be linked to very rare cases of blood clotting.

Scientists have known for decades that coronaviruses can cause disease in dogs, but there has not been any evidence that dogs transmit it to humans.Credit…Alen Thien/Alamy

Scientists have discovered a new canine coronavirus in a child who was hospitalized with pneumonia in Malaysia in 2018. If the virus is confirmed to be a human pathogen, it would be the eighth coronavirus, and the first canine coronavirus, known to cause disease in humans.

It is not yet clear whether this specific virus poses a serious threat to humans, the researchers stress. The study does not prove that the pneumonia was caused by the virus, which may not be capable of spreading between people. But the finding, which was published on Thursday in Clinical Infectious Diseases, highlights the need to more proactively search for viruses that could jump from animals into humans, the scientists said.

“I think the key message here is that these things are probably happening all over the world, where people come in contact with animals, especially intense contact, and we’re not picking them up,” said Gregory Gray, an infectious disease epidemiologist at Duke University who is one of the study’s authors.We should be looking for these things. If we can catch them early and find out that these viruses are successful in the human host, then we can mitigate them before they become a pandemic virus.”

Seven coronaviruses are currently known to infect humans. In addition to SARS-CoV-2, which is the causes of Covid-19, there are coronaviruses that cause SARS, MERS and the common cold. Many of these viruses are believed to have originated in bats, but can jump from bats to humans, either directly or after a stopover in another animal host.

Scientists have known for decades that coronaviruses can cause disease in dogs, and recent studies have shown that the coronavirus that causes Covid-19 can infect both cats and dogs. But there has not been any evidence that dogs transmit it, or any other coronavirus, to humans.

global roundup

Treating a patient in Lomas de Zamora, Argentina, on May 8. The country hit its highest daily death rate on Thursday.Credit…Natacha Pisarenko/Associated Press

President Alberto Fernández of Argentina ordered a nine-day lockdown in the worst-affected parts of the country to help curb the spread of the coronavirus as the nation struggled to contain a second wave of the outbreak.

In a speech broadcast nationally on all radio and TV stations, Mr. Fernández ordered a lockdown that starts on Saturday and ends on May 30 in those regions. That will be followed by another nine days of restrictions, the severity of which will be determined by how much the country is able to control the spread of the virus.

“We are living the worst moment since the start of the pandemic,” Mr. Fernández said. “If we follow the guidelines, we will reduce the impact of this second wave. It is imperative that every local jurisdiction strictly apply these guidelines. There is no space for speculation and there is no time for delay.”

Argentina, like many of its neighbors in Latin America, saw an alarming spike in cases in April that has shown little respite as the region struggles to vaccinate people quickly enough to slow the spread. In the last seven days, the country’s daily average of new cases soared to become the fourth-highest in the world, and deaths rose to be the fifth-highest.

On Thursday, Argentina recorded 39,652 new cases and 494 new deaths. So far, 18 percent of the population has received at least one dose of a vaccine and 4.7 percent are fully vaccinated, according to the Our World in Data project at the University of Oxford. Neighboring Chile has fully vaccinated 40 percent of its population.

In other developments around the globe:

  • Thailand has detected its first 15 domestically transmitted cases of the highly infectious coronavirus variant first found in India, Reuters reported. The cases were discovered among construction workers in Bangkok, the Thai coronavirus task force said on Friday.

  • Prime Minister Pedro Sánchez of Spain announced on Friday that visitors from Britain, Japan, China and a handful of countries would be allowed back into the country from Monday, while Americans and other people who have been vaccinated will be able to visit Spain from June 7. The return of British tourists, who form the largest contingent of holiday makers in many Spanish resorts, was seen as essential to help guarantee the recovery of the Spanish tourism sector. “Spain will be very happy to welcome British tourists,” Mr. Sánchez said, during a tourism conference in Madrid. “They are welcome into our country without restrictions.”

  • While the government of Britain still advises against international cruises, a ship embarked on a domestic journey on Thursday night, the first time any such vessel had set sail from the country for more than a year. Passengers for the four-night cruise around the British Isles had to test negative for the virus before boarding and social distancing and masks are still required in public areas

  • Norway plans to ease some virus restrictions beginning May 27, Reuters reported. Larger groups of people will be allowed to meet and alcohol will be allowed to be served until midnight, Prime Minister Erna Solberg said on Friday. In some places, though, local restrictions will remain tougher than the national rules to prevent regional flare-ups of the virus.

Raphael Minder and Anna Schaverien contributed reporting.

After 14 months of lockdowns — some light, some draconian — many in Europe are again allowed to grab a coffee at a cafe or a pint in a pub, and to stay at a hotel or at a bed-and-breakfast.

Lockdown rules intended to prevent the spread of the coronavirus have been eased in England, France, Germany, Greece, Italy, the Netherlands and Poland, among other places — with many of the restrictions falling away this week.

The virus has killed more than 3.4 million people and sickened more than 165 million. But in Europe, with vaccinations rising, normalcy is once again at hand. After a rough start, 33 percent of people in the European Union have gotten at least one vaccine shot, according to Our World in Data, a University of Oxford tracking site. In Britain, 37 million people have received one dose of the vaccine and 21 million are fully vaccinated.

On Wednesday in Paris, where cafe terraces were once again open, Saïd Belkhiati, a 27-year-old account manager was dressed in a suit and having a drink with a friend.

“It really changes everything,” he said. “For a year, I felt like I was imprisoned, in an open-air jail. Now we are free. I’m enjoying this first breath of freedom. I took a day off to enjoy the reopening. Having a drink here, it’s so nice. Terraces are what make the charm of Paris!”

Noëlle Roche, a 75-year-old retiree, ventured out in the rain in Paris to catch up on a beloved pastime, going to the movies.

“I just watched the movie ‘DNA,’” she said. “I’m happy to be able to go to the movies again,”

“I missed it so much,” she added. “I usually go to the movies several times a week.”

In England, where indoor dining was allowed to restart and movie theaters and museums reopened, there was a note of caution because a variant of the virus that is circulating in India has also been found in Britain.

“We must be humble in the face of this virus,” the health secretary, Matt Hancock, told Parliament on Monday, adding that the variant, with a higher transmission rate, “poses a real risk.” While the overall case numbers remain low, they have been multiplying rapidly.

In Berlin, terraces, beer gardens and outdoor seating at restaurants opened on Friday. Despite some clouds and rain, owners and staff had been preparing all week, taking chairs and tables out of storage, and setting up the kind of tent-like structures that will allow customers nearly all the comforts of indoor dining while staying in line with the current coronavirus guidelines.

Those enjoying the outdoor services will have to present either a vaccination documentation, proof of an old Covid infection or a negative antigen test, which can be taken in one of hundreds of free test stations that the government has funded.

Other attractions, like museums, memorials and some outdoor theaters and cinemas, were opening on Friday under a reservation-only system, under the same testing-vaccine rules as the restaurants.

“It’s just grand — we are so happy that we can open up again and that we can have tourists sitting on our terrace,” said Jan Bubinger, 36, one of the managers at the Ständige Vertretung, a pub and restaurant on the Spree River right in the middle of Berlin’s tourist district.

Mr. Bubinger, who has had to shutter his restaurant for seven months, added that he would make antigen tests available to those without documents so that they don’t have to go to a test center before being served.

Volker Pradel, 61, said, “We are very happy of course,” after welcoming his first guest to the Schleusenkrug, a beer garden close to the Berlin Zoo on the west side of the city. Mr. Pradel, the manager of the eatery, noted, however, that it was difficult finding servers because most people in that profession now work at test or vaccination centers.

A doctor attending to a Covid-19 patient at a hospital in Kotputli area of Rajasthan in India, last week.Credit…Rebecca Conway/Getty Images

India’s federal health ministry raised an alarm on Thursday, asking state governments to immediately report all cases of a potentially deadly fungal infection that appears to be spreading quickly among Covid-19 patients.

The rare condition, mucormycosis, commonly known as black fungus, was present in India before the pandemic, but it is affecting those with Covid or those who have recently recovered.

Many health experts blame the spread on a central coronavirus treatment, steroids. These drugs can limit inflammation of the lungs, but they also dull the response of the immune system, which can allow infections like the black fungus to take hold.

More broadly, Covid patients with weakened immune systems and underlying conditions, particularly diabetes, are especially vulnerable to black fungus, which has a high mortality rate.

Making matters worse, a shortage of antifungal drugs, like amphotericin B, has made it hard to fight the infection once it attacks. Relatives of the sick have been desperately sending messages over social media seeking the drug.

Courts are pressuring local governments to make antifungal drugs available and pushing for stepped up investigations to stop black-market drugs from being distributed.

Before the pandemic, a vial of amphotericin B would cost around $80, but some relatives of sick people say they have paid as much as $500 on the black market.

Video of a woman saying she would jump off the roof of a hospital if it failed to arrange injections of the medication for her husband spread widely on social media early this week.

The woman, in the central Indian state of Madhya Pradesh, said, “If I don’t get the injection today, then I will jump off the roof of the hospital and commit suicide. I have no other option left.” She added that the hospital had none of the medication and said of her husband, “Where should I take him in this condition?”

In the western state of Maharashtra, which includes the commercial hub of Mumbai, the authorities said at least 90 people had died of fungal infections and more than 1,500 patients were being treated in hospitals.

Rajesh Topai, the health minister of Maharashtra, told reporters on Wednesday that the state was desperate for more supplies of the medicine and begged the federal government, “do anything, but give more vials to Maharashtra.”

In Delhi, the capital, badly hit by the pandemic, hospitals have recorded 185 fungal infection cases and the local government is setting up three dedicated centers inside government-run hospitals to treat the condition.

M.V. Padma Srivastava, a professor and head of neurology department at All India Institute of Medical Sciences, New Delhi, said the number of black fungus cases was increasing every day and the condition was appearing across the country like never before.

She said hospitals received few cases during the first wave of the pandemic but certainly not the numbers they are registering now, amid a virulent second wave.

Of the medication for the disease she said: “It is not one of the common over-the-counter medications. This is a toxic medication by itself. It can’t be given by all and sundry. It is not something which you can take at home. It needs strict monitoring of body parameters because it is a toxic drug.”

The federal government directive requiring state governments to immediately disclose cases follows those of many Indian states that had already required hospitals to report cases of mucormycosis.

A mobile vaccination clinic in Los Angeles last week.Credit…Patrick T. Fallon/Agence France-Presse — Getty Images

Los Angeles is taking its vaccination efforts on the road.

The city is gradually winding down its mass vaccination sites and will be fully mobile starting Aug. 1, marking what one deputy mayor called “the end of an era.”

“It’s a natural evolution,” said Jeffrey Gorell, the deputy mayor for public safety, who is overseeing vaccine efforts in the city. “Rather than having fixed sites where we ask community members to come to us, the natural progression is for us to move into more of a mobile approach where we can go to the populations where we need to be for areas with the lowest vaccination rates.”

With mobile sites, “we believe we can get to the most challenged areas,” he said.

Mobile vaccine units have been a part of the city’s vaccine program. But as the city’s 10 mass vaccination sites close over the coming weeks, the city will up its mobile units from 10 to 14. The city stopped offering vaccines at Dodgers Stadium on Thursday but other mass sites remain open.

Specially outfitted vans and trailers will give the city “tactical vaccination capabilities” so they can get into communities that may be underserved, hesitant or simply don’t have the time because of work requirements, Mr. Gorell said, adding that mobile teams will be able to extend evening and weekend hours.

“Rather than hunker down at a fixed site waiting for them to come to us, we can be in their neighborhood and available,” Mr. Gorell said. “We’re going to be a truly mobile presence in the city.”

The mobile units will offer all three federally authorized vaccines — the two-dose Pfizer-BioNTech and Moderna vaccines, and the single-shot Johnson & Johnson — and will be able to travel to multiple neighborhoods a day or stay for an entire week. Mr. Gorell said they also plan to target community events, grocery stores, street fairs and other highly trafficked areas. Appointments will not be necessary.

As of Thursday, 54 percent of California residents have received at least one shot and 40 percent are fully vaccinated according to a New York Times database. In Los Angeles County, 40 percent of eligible residents are fully vaccinated.

“With a growing number of residents getting inoculated, we are putting our resources where they will do the most good — delivering doses directly to undervaccinated communities, engaging and educating vulnerable populations, and eliminating barriers to this life-saving vaccine,” Mayor Eric Garcetti said in a statement.

Los Angeles joins a growing fleet of mobile Covid-19 vaccine clinics that are rolling up to neighborhoods in Delaware, Minnesota and Washington State to reach people who have been unable to travel to vaccination centers.

The city is working with community based organizations to help residents understand the science of the vaccine and access the mobile sites.

For Denise Villamil, the director of youth development services at Alma Family Services in East Los Angeles, outreach has been both personal and professional. Ms. Villamil lost her aunt to Covid-19 in December, just a month before vaccines started becoming available in the United States.

“Every person I can get through the line, every person I can get through the registration is one more person who is luckier than those who didn’t in the pandemic,” Ms. Villamil said. “Fear spreads, so does hope. So we’ve seen that in the communities and that’s been the beautiful part of this process. We’ve been able to give hope and see the ripple effect.”

Gov. Larry Hogan of Maryland has enlisted the help of the state’s lottery to get more people vaccinated.Credit…Patrick Siebert

It’s not every day that an American governor appears alongside a man dressed as a lottery ball.

But that’s exactly what happened on Thursday as Gov. Larry Hogan announced that Maryland would partner with the state’s lottery to provide $2 million in prize money for residents who get vaccinated.

“Our mission is to ensure that no arm is left behind and we’re committed to leaving no stone unturned and using every resource at our disposal to achieve that goal,” Mr. Hogan said.

Beginning May 25, the Maryland lottery will randomly select and award $40,000 to a vaccinated Marylander every day through July 4, when a final drawing will be held for a grand prize of $400,000. Any Maryland resident who has been vaccinated in the state will be automatically enrolled in drawings.

“The sooner you get your shot, the more lottery drawings you will be eligible for,” he said, adding, “There’s no better time than now and there should be no more excuses.”

The state has administered about 5.7 million vaccines, and 44 percent of the state is fully vaccinated, according to a New York Times database. But like other states across the country, vaccination rates have tapered off. States have turned to an array of incentives — including beer, money, transit cards and joints — to get shots into the arms of more Americans.

“Promotions like this are just one more way that we’re reinforcing the importance of getting every single Marylander we can vaccinated against Covid-19,” Mr. Hogan said. All funding will be provided from Maryland’s lottery marketing fund.

“Get your shot for a shot to win,” he said, adding, “that’s a good line.”

Maryland isn’t alone in trying to lure residents with the chance of big winnings. This month, Ohio’s governor, Mike DeWine, offered a $1 million lottery prize for five people who get vaccinated. That effort would be paid for by federal coronavirus relief funds, Mr. DeWine said during a statewide televised address.

And in New York, the state will hand out free scratch-off tickets for the “Mega Multiplier” lottery to those 18 and older who get their shot at 10 state mass vaccination sites next week, Gov. Andrew Cuomo said on Thursday. The pilot program lasts from next Monday to Friday. The tickets could yield prizes from $20 to the $5 million jackpot, he said.

A summer camp in Michigan last year.Credit…Emily Elconin/Reuters

As vaccinated Americans return to many parts of their prepandemic lives this summer, one group will be left out: children under 12, who cannot yet be vaccinated. So what should families with young children do when everyone else starts socializing again?

We asked experts as part of an informal New York Times survey. The group of 828 who responded included epidemiologists, who study public health, and pediatric infectious disease physicians, who research and treat children sick with diseases like Covid-19.

They noted that this phase was temporary. Pfizer has said vaccines for children ages 2 and up could come as soon as September. Of the survey respondents with young children, 92 percent said they would vaccinate their own children as soon as a shot was approved.

In the meantime, families with young children may need to retain more precautions, like masking and distancing, than their childless friends do. But they said some minimally risky activities could help counteract the mental health effects of pandemic living.

“Kids need to be able to be kids,” said Mac McCullough, an associate professor at Arizona State. “Outdoor activity isn’t perfectly safe, but its benefits are likely to outweigh its risks across an entire population.”

Dining in Florence, Italy, this week. Pressure has built on the government to be more flexible to save the tourism season and to allow Italians to get vaccinated in sun-and-surf regions far from home.Credit…Susan Wright for The New York Times

ROME — As Dr. Mario Sorlini sits patients down in a vaccination center near the badly affected Italian town of Bergamo, he explains a potential complication of the coronavirus vaccine.

The second dose, he tells patients with terror-stricken faces, will fall on a date during the summer holidays.

“‘But I’ll be in Sardinia then,’” he said that some had responded with distress. Others moan about hotel rooms they’ve already booked. Some, he said, get up and leave.

For months, Italians have hungered for the vaccines that would give them safety, freedom from lockdown and a taste of normal life. After initial pitfalls and hurdles, the vaccination campaign is finally speeding up, but it is heading smack into the summer holidays that are sacred for many Italians and prompting fears among officials that a significant number would rather get away than get vaccinated.

“I am certain that many, after such a hard year, will risk delaying the vaccine” until after the summer holidays, said Renata Tosi, the mayor of Riccione, a beach town that is so identified with summer flings that it lent its name to a recent vacation anthem. That could create a significant danger next autumn, Ms. Tosi wrote in an open letter to the region’s president.

“The Second Shot Blocks Vacation,” read a headline in Messaggero Veneto, a newspaper in northeastern Italy, echoing concerns in papers, websites and social media accounts across the country.

An estimated 20 million Italians — mostly 40- and 50-somethings — face the prospect of getting their second shots in the middle of July or worse, in the riptide that is the Italian August, which pulls people out of cities and into swelling seaside towns.

This year, people have sought vacations with such a vengeance that tourism operators have started using the term “revenge travel” to describe the way Italians are trying to get even with the cruel months of lockdown. Surfing the web for holiday homes has become the new doom scrolling.

Categories
Business

International locations Are Scrambling for Vaccines. Mongolia Has Loads.

Mongolia, a land of grassy hills, vast deserts, and endless skies, has a population not much larger than Chicago’s. The small democratic nation is used to living in the shadow of its powerful neighbors Russia and China.

But during a pandemic, there can be benefits to being a small nation sandwiched between two vaccine makers with global ambitions.

At a time when most countries are looking for coronavirus vaccines, Mongolia now has enough to fully vaccinate its entire adult population, thanks in large part to treaties with China and Russia. The officials are so confident that they promise citizens a “Covid-free summer”.

Mongolia’s success in obtaining the vaccines within a few months is a huge victory for a low-income developing country. Many poor countries have waited in line for shots, hoping for the best. But Mongolia, taking advantage of its status as a small geopolitical actor between Russia and China, was able to buy cans in a similar clip as it did in much richer countries.

“It speaks to the Mongolian ability to play against the two great powers and maximize their advantages even when they are walking a tightrope between the two countries,” said Theresa Fallon, director of the Center for Russia-Europe-Asia Studies in Brussels.

It’s also a win for China and Russia, which have extensive resource interests in Mongolia and ambitions to play a role in ending the pandemic, even if much of the world has expressed deep skepticism about their homegrown vaccines.

Mongolia is a buffer between Eastern Russia, which is resource-rich and largely uninhabited, and China, which is overcrowded and resource-hungry. While Russia and China are often aligned on the global stage, they have a history of conflict and are aware of mutual interests in Mongolia. These suspicions can be seen in their vaccine diplomacy.

“Putin is deeply concerned about what China is doing in its neighborhood,” Ms. Fallon said of Russian President Vladimir V. Putin.

Russia sold a million doses of its Sputnik V vaccine to Mongolia. China has provided four million doses of vaccine – the final shipment of the doses arrived this week. Mongolia’s most recent agreement with the state-owned Chinese Sinopharm Group was made a few days before the World Health Organization received the emergency approval.

Mongolia was late for Covid-19 vaccines worldwide. For almost a year, officials boasted that there were no local cases. Then there was an outbreak in November. Two months later, the political crisis sparked by the abuse of the virus resulted in the Prime Minister’s sudden resignation. The prospect of ongoing coronavirus restrictions threatened to plunge the country into further political turmoil.

The new prime minister, Oyun-Erdene Luvsannamsrai, pledged to restart the economy that had suffered from lockdowns and border closings, particularly in the south, where Mongolian truckers are hauling coal across the border with China’s steel mills. But these plans were complicated by the growing number of cases, with the daily number rising from hundreds a day to thousands.

“We were pretty desperate,” said Bolormaa Enkhbat, an economic and development advisor to Mr. Luvsannamsrai.

Mongolia turned to China and Russia first, the foreign minister said in hopes that longstanding economic ties with each country would help put it at the forefront of vaccine-looking countries. Officials simultaneously explored diplomatic and private channels, soliciting donations from rich countries and the world’s largest vaccine manufacturers.

Updated

May 19, 2021, 8:11 p.m. ET

They contacted award-winning middlemen, international health organizations and vaccination alliances for poorer countries. An intermediary offered to sell Pfizer-BioNTech’s Covid vaccine for $ 120 per shot, which is nearly a quarter of the average monthly salary, Ms. Enkhbat said. Covax, the global vaccine sharing alliance that Mongolia signed in July 2020, promised doses in the fall or winter.

With each breakthrough from Russia, negotiations with China moved faster.

At the beginning of February, Mongolia approved the Russian vaccine Sputnik V. Three days later, the Chinese Sinopharm Group received approval for its Vero Cell vaccine. Soon after, China donated 300,000 doses of its Sinopharm vaccine to Mongolia, citing a “deep traditional friendship” as motivation.

The opening of the border between China and Mongolia was also part of the vaccine discussions, Chinese and Mongolian officials said in Chinese state media. Mongolia needs China to buy its coal – exports to the country account for almost a quarter of Mongolia’s annual economic growth. The revenue helped add a quarter to Mongolia’s budget last year.

After a month of back and forth, in March the Mongolian government also signed a contract with the Russian Gamaleya Research Institute for one million doses of the Sputnik vaccine. Days later, Mongolia entered into an agreement to purchase 330,000 additional doses of the Sinopharm vaccine.

When last-minute problems arose with delivery of the purchased Chinese vaccines, a phone call between China’s Prime Minister Li Keqiang and Mongolian Prime Minister Luvsannamsrai on April 7 helped smooth things out and reassure both sides. Until then, it was unclear whether Mongolia could rely on China or whether it would have to return to Russia for more vaccines.

“That paved the way for the rest of the business,” Ms. Enkhbat said of the call, Mr. Luvsannamsrais first with Mr. Li. “We set out the situation and said that we are betting on Chinese vaccines, at one time that the rest of the world is not. “

Mongolia has also received commitments from AstraZeneca and Pfizer-BioNTech. So far, it has only received 60,000 Sputnik vaccines due to manufacturing delays. But the Chinese vaccine will account for a large part of the Covid-19 shots for the Mongolian population.

“We are grateful to our partners, especially China, for providing us with vaccinations when they need them for home use,” said Battsetseg Batmunkh, Mongolia’s Foreign Minister.

The Chinese and Russian embassies in Mongolia did not respond to requests for comment.

in the UlaanbaatarIn the capital of Mongolia, 97 percent of the adult population have received a first dose and, according to government statistics, more than half are fully vaccinated. Across the country, more than three quarters of Mongolians have already received a shot.

The country’s vaccination efforts still face hurdles. Mongolia is economically dependent on China and many of its citizens continue to fear its power and influence. When tensions arose in the past, China closed its border and stopped buying Mongolian coal.

The Mongols also preferred the Russian Sputnik vaccine. To get the population to take the Sinopharm shot, the government has offered each citizen 50,000 tugriks – about $ 18 – to get fully vaccinated. The median monthly salary in 2020 was $ 460.

The terms and prices of the Sinopharm and Sputnik deals were not made public and the Mongolian Foreign Ministry declined to comment on the prices. Representatives from the Gamaleya Research Institute and Sinopharm did not respond to requests for comment.

While some global health experts have questioned whether Sinopharm can continue to meet its overseas commitments, it has delivered all of the cans Mongolia ordered. China has announced it will deliver up to five billion doses by the end of the year, despite officials warning the country is struggling to get enough shots for its citizens.

There is also evidence that governments that have chosen the Sinopharm vaccine may have to introduce a third booster shot earlier than expected.

For its part, China could play a long game, said Julian Dierkes, an associate professor at the University of British Columbia who specializes in Mongolian politics. Although many Mongolians still do not trust China, the Mongolian government will remember how it made their vaccines available at a critical moment.

“We could coin a sentence here: ‘The opportunity of smallness’,” he said.

Categories
Health

Covid-19 Vaccines: Novavax Stories Extra Delays

Novavax, one of the earliest players in the world’s vaccination race against Covid, delivered disheartening news Monday, saying its highly protective vaccine would not be approved in the US or UK until July and would not reach peak production by the end of the year.

The delays announced during a profit call with investors are the most recent setback for the little-known Maryland company that received up to $ 1.6 billion from the federal government last year and its product is in clinical trials has shown robust results. Despite these achievements, the company has struggled to show it can deliver on its promise to bring 2 billion doses to the world this year. Novavax has never launched a vaccine in its 34-year history.

Speaking on the conference call, the company’s President and Chief Executive Officer Stanley C. Erck said the regulatory and manufacturing hurdles causing the delay have now been resolved. “Almost all of the major challenges have been overcome and we can clearly see the light at the end of the tunnel,” he said.

Investors didn’t seem to agree: by Tuesday morning, the company’s stock had fallen to $ 133.86, down nearly 17 percent, although it rebounded a little later in the day.

“I don’t see much good for them right now,” said Rob Smith, general manager of Capital Alpha Partners, an investment research firm.

The company’s delay is unlikely to affect wealthy countries like the US, which are being flushed with vaccines from Moderna, Pfizer-BioNTech, and Johnson & Johnson.

It’s likely that this will have a significant impact on the rest of the world, however, as Novavax only signed a deal with Gavi, a public-private global vaccine partnership, last week to sell 1.1 billion doses of its shot at low and medium levels – to deliver. Income Countries. Novavax has other contracts with countries such as South Korea, Japan and Australia and has agreements with eight manufacturing facilities around the world.

In January, the company estimated it would reach its full production capacity of 150 million cans per month by the middle of this year. This forecast was later revised after a lack of supplies such as filters and the huge disposable bags used in vaccine production. On Monday, the company delayed its estimate again, anticipating production of 100 million cans per month by the end of the third quarter and production of 150 million cans per month by the fourth quarter.

One of its key manufacturing partners, the Serum Institute in India, has faced its own manufacturing and geopolitical challenges. A fire at the facility earlier this year reduced capacity, and in April Adar Poonawalla, director of Serum, urged the United States to restrict access to raw vaccine ingredients. And although Novavax’s contract with serum aims to serve the rest of the world through its agreement with Gavi, the Indian government has banned the export of vaccines from the country as it grapples with a deadly second wave of Covid-19.

“Serum is the backbone of global vaccine supplies,” said Andrea Taylor, associate director of the Duke Global Health Innovation Center, which pursues global vaccine businesses. “I think for countries in South and Southeast Asia in particular, as well as for countries in Africa, it is difficult to overestimate the impact this will have.”

Novavax has also thrown back regulatory hurdles. On Monday, company executives said a problem now resolved with an “assay” – a test that was required to confirm that their product could be consistently manufactured on a commercial scale at multiple factories – was gaining regulatory approvals around the world Delayed countries like the UK and the United States would not give approval until July. The company’s employees once said they were hoping to get approval for their vaccine in April.

The delay is particularly noticeable in the UK, where Novavax reported positive results from its clinical trial in January.

British officials convinced Novavax to set up a study there last year, partly because they promised rapid clinical development and regulatory approval. But time is running out: around two-thirds of UK adults have received an initial dose of a coronavirus vaccine, largely made by AstraZeneca, and each adult is expected to be offered one by the end of July.

Updated

May 11, 2021 at 4:32 p.m. ET

The role of the vaccine in the UK depends in part on how quickly Novavax can start distributing its vaccine. A UK factory that makes the vaccines has announced that they will be ready by the summer. The country recently turned away from AstraZeneca intake in younger people because of the risk of very rare blood clots, so Novavax may be an alternative for people under 40.

The country is also investigating the effects of giving a second dose of the Novavax vaccine to people who have already received a first dose of Pfizer or AstraZeneca.

In the US, the Novavax setback sheds new light on the massive deal with the US government. As recently as 2019, the company was on the verge of closing after another vaccine made a major trial and had to sell its manufacturing facility to raise money.

Last year, the Trump administration placed a big bet on the tiny company as part of its Operation Warp Speed ​​project, signing a $ 1.6 billion contract earlier this year to supply 110 million cans. In April, the total amount of the deal increased to $ 1.75 billion, according to Novavax. The company’s major study in the United States and Mexico is still ongoing, despite executives on Monday that they expected the results of that study “in a few weeks.”

Novavax officials said they now didn’t expect to deliver these doses by the end of this year or early 2022. A Novavax spokeswoman said there was no penalty for later delivery in her contract with the U.S. government.

Novavax’s spotty track record offers no confidence in the challenge of producing billions of cans, said Les Funtleyder, healthcare portfolio manager at E Squared Capital Management, which invests in domestic and emerging markets. “It seems they really weren’t prepared for a challenge of this magnitude,” he said.

Recent news about internal sales – such as the departure of Novavax’s chief financial officer last month, five months after he took office for personal reasons – doesn’t help, Funtleyder said. “It’s a bad look,” he said.

But even if there’s a challenging path to follow as a straggler, Novavax’s vaccine could fill important loopholes, some experts said. In the United States, it could be used as a booster shot to bolster dwindling immunity, or the Biden government could choose to donate the vaccine to other countries in need, as it does with the unused supply of AstraZeneca doses .

Novavax has announced that it will develop a new version of its vaccine to address the variant circulating in South Africa. And it was recently announced that it would be investigating the shot in children over the age of 12 to catch up with Moderna and Pfizer, who have already tested their products in that age group.

The vaccine can also be stored at normal refrigeration temperatures without the freezing temperatures required for Pfizer and Moderna vaccines.

“By the end of 2021, there will still be a great need for safe, effective vaccines that can travel well,” said Ms. Taylor of Duke University. “Novavax seems to fit that description.”

Dr. Saad B. Omer, director of the Yale Institute for Global Health, noted that countries with multiple vaccines available were able to switch to other options when concerns about Johnson & Johnson and AstraZeneca vaccines were raised due to blood clot association.

“It’s good to hedge our bets,” he said. “For example, if we want to avoid one body blow after another in low-income countries in many parts of the world that affects everyone, we have to vaccinate a large part of the world.”

Benjamin Mueller and Noah Weiland contributed to the reporting.

Categories
World News

Covid-19 Reside Updates: Vaccines, Variants and Circumstances

Here’s what you need to know:

Credit…Ognen Teofilovski/Reuters

The World Health Organization on Friday approved China’s Sinopharm’s Covid-19 vaccine for emergency use, easing the way for poorer nations to get access to another much-needed shot to help end the pandemic.

The approval allows the Sinopharm vaccine to be included in Covax, the World Health Organization’s global initiative that is designed to promote equitable vaccine distribution around the world.

The need is dire.

Rich countries are hoarding doses. India, a major vaccine maker, has stopped exports to address its worsening coronavirus crisis. Questions about safety after exceedingly rare side effects led some countries to briefly pause using AstraZeneca and Johnson & Johnson doses or change their guidance around the use.

Reliable vaccine access could improve further next week when the W.H.O. considers another Chinese shot, made by the company Sinovac.

Andrea Taylor, who analyzes global data on vaccines at the Duke Global Health Institute, called the potential addition of two Chinese vaccines into the Covax program a “game changer.”

“The situation right now is just so desperate for low- and lower-middle-income countries that any doses we can get out are worth mobilizing,” Ms. Taylor said. “Having potentially two options coming from China could really change the landscape of what’s possible over the next few months.”

But the fanfare may be short-lived. While China has claimed it can make up to 5 billion doses by the end of this year, Chinese officials say the country is struggling to manufacture enough doses for its own population and are cautioning a pandemic-weary world to keep expectations in check.

“This should be the golden time for China to practice its vaccine diplomacy. The problem is, at the same time, China itself is facing a shortage,” said Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations. “So in terms of global access to vaccines, I don’t expect the situation to significantly improve in the coming two to three months.”

Still, the approval represents a high point in its vaccine diplomacy efforts and a chance to fill the gap left by Western nations and pharmaceutical companies in low- and middle-income countries. Sinopharm is the first Chinese shot to be classified as safe and effective by the W.H.O., and its approval could ease concerns about the lack of transparency from Chinese vaccine companies.

Regulators from China and other countries have approved the Sinopharm vaccine in recent months, though the company has not released Phase 3 clinical trial data for scientists to independently assess.

The W.H.O. was given access to this data before the announcement, but there is limited data on how well the vaccine will work against the many coronavirus variants cropping up around the world.

United States › United StatesOn May 6 14-day change
New cases 47,325 –27%
New deaths 818 –4%
World › WorldOn May 6 14-day change
New cases 856,719 Flat
New deaths 13,873 +9%

U.S. vaccinations ›

Where states are reporting vaccines given

Ton Tran, 106, receiving his second dose of the Pfizer-BioNTech Covid-19 vaccine at a clinic in San Jose, Calif., on Thursday.Credit…Noah Berger/Associated Press

Pfizer and the German company BioNTech have become the first companies to apply to the U.S. Food and Drug Administration for full approval of their Covid-19 vaccine for use in people 16 and older. The vaccine is currently being administered to adults in America under an emergency use authorization granted in December.

The approval process is likely to take months.

The companies said in a statement on Friday that they had submitted their clinical data, which includes six months of information on the vaccine’s safety and efficacy, to the F.D.A. They plan to submit additional material, including information about the manufacturing of the vaccine, in the coming weeks.

“We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S. government,” Dr. Albert Bourla, Pfizer’s chief executive, said in the statement. “We look forward to working with the F.D.A. to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months.”

As of Thursday, more than 134 million doses of the vaccine had been administered in the United States, according to the Centers for Disease Control and Prevention. Full approval would allow Pfizer and BioNTech to market the vaccine directly to customers.

It could also make it easier for companies, government agencies and schools to require vaccinations. The Equal Employment Opportunity Commission said in December that employers could mandate vaccination, and legal experts have generally agreed.

Many companies have been hesitant to require the vaccines, especially while they have only emergency authorization, which is designed to be temporary. Some institutions, like the University of California and California State University systems, have said that they would do so only after a vaccine has full approval.

Full approval could also prompt the U.S. military, which has had low uptake of Covid-19 vaccines, to mandate vaccinations for service members.

If the F.D.A. grants full approval, it could also help raise confidence in the vaccine. The pace of vaccination has slowed in the United States in recent weeks, and a recent national survey indicated that most people in the country who planned to get the shots had already done so.

The agency is also expected to issue an emergency authorization for use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds next week. The companies have said that they plan to file for emergency authorization for 2- to 11-year-olds in September.

Moderna plans to apply for full approval for its Covid-19 vaccine this month, the company said during its quarterly earnings call on Thursday.

Director of the Center for the National Center for Immunization and Respiratory Diseases Dr. Nancy Messonnier spoke in Washington in January 2020.Credit…Amanda Voisard/Reuters

Dr. Nancy Messonnier, who famously warned the nation early last year that the coronavirus would upend their lives, resigned from her position at the Centers for Disease Control and Protection on Friday.

Dr. Messonnier’s resignation is effective May 14. She is taking on a new role as an executive director at the Skoll Foundation, a philanthropical organization based in Palo Alto, Calif., she told staff in an email on Friday.

Her exit may augur more changes at the agency. Reports have circulated for weeks that the C.D.C.’s new director, Dr. Rochelle Walensky, planned to completely reorganize the division Dr. Messonnier led.

“My family and I have determined that now is the best time for me to transition to a new phase of my career,” Dr. Messonnier wrote in the email to staff.

Dr. Messonnier began her career in public health in 1995 with a stint in the prestigious Epidemic Intelligence Service. She has since held a number of leadership posts in the C.D.C. Since 2016, she has served as director of the National Center for Immunization and Respiratory Diseases, the C.D.C. division responsible for managing influenza and other respiratory threats.

In late 2019, she became the agency’s lead in responding to the coronavirus, and initially shared a stage with President Trump at briefings about the coronavirus.

She fell out of favor with President Trump and sent stocks tumbling after she sounded a dire alarm about the coronavirus, saying it would disrupt the lives of every American.

“It’s not a question of if this will happen but when this will happen and how many people in this country will have severe illnesses,” she said on Feb. 25, just as Mr. Trump was boarding Air Force One in New Delhi for his flight home.

Soon after that, she stopped appearing at briefings of the White House and of the C.D.C.

Patients with Covid-19 in the emergency ward at the Holy Family hospital in New Delhi on Thursday.Credit…Rebecca Conway/Getty Images

India’s worsening coronavirus outbreak has spread far outside its cities to rural areas with poor health care infrastructure and limited testing capacities, doctors and experts say.

One factor behind the surge of cases, they believe, is a series of recent campaign rallies held without social distancing.

The state of West Bengal, where Prime Minister Narendra Modi’s party lost an election last week after more than a month of campaigning to vast crowds, is recording the highest rate of positive coronavirus tests in the country. More than 31 percent of tests in the state are now coming back positive.

“There is a clear pattern here: States that went through elections and where large rallies were held are witnessing a huge rise in cases,” said Dr. Thekkekara Jacob John, a senior virologist in the southern state of Tamil Nadu.

In Uttar Pradesh, India’s most populous state, 1,028 new coronavirus cases and four deaths were recorded on March 26. On April 29, after campaigns for local village council elections were held, there were 35,104 cases and 288 deaths. A teachers’ union in the state said that 577 teachers and support staff members who were on duty as election workers had died of Covid-19.

The country’s cases as a whole have been skyrocketing since late March, from a seven-day average of more than 62,000 on March 31 to more than 385,000, according to the Our World in Data project at the University of Oxford. On Friday, the country reported more than 410,000 new daily infections, a record, and more than 3,900 deaths.

As the outbreak reaches new heights, India’s vaccination campaign has slowed down, marred by supply shortages and competition among states.

The official daily death in the country has stayed over 3,000 over the past 10 days, and experts say the numbers are much higher,.

The true scope of the outbreak remains hard to measure. Nationwide, India conducted about 1.9 million coronavirus tests on Thursday, an increase from about 1.2 million daily tests last month, but hardly enough to keep up with a daily caseload that has almost quadrupled in that time.

West Bengal, a state of 90 million people that has poor health care infrastructure and is under a partial lockdown, has carried out fewer than 60,000 coronavirus tests a day. That is one of the lowest rates in the country, according to data compiled by researchers at the University of Michigan.

Dr. Abhijeet Barua, a physician in Kolkata, the state’s capital, said that cases had exploded in every corner of the city and that infections were spreading quickly in the state’s rural areas. At his 10-bed clinic, two people have died every day over the past 15 days, Dr. Barua said.

“What is making things worse in Kolkata is that over 70 percent of the population lives in close contact,” he said, adding that he was receiving dozens of calls a day from patients seeking help. “You can’t isolate yourself, because it is so congested here.”

Mr. Modi has repeatedly refrained from imposing a nationwide lockdown. Instead nearly a dozen of India’s 28 states have imposed restrictions, though they are less stringent than the nationwide lockdown put in place last year.

Protective masks are worn in March in Tokyo, the host of this summer’s Olympic Games.Credit…Noriko Hayashi for The New York Times

TOKYO — Japan on Friday extended a state of emergency in Tokyo and other regions until the end of May to contain a surge of coronavirus cases, casting further doubt on the country’s ability to safely host the Summer Olympics, which are scheduled to begin in 11 weeks.

Prime Minister Yoshihide Suga made the announcement at a meeting of the government’s coronavirus task force, saying that the measures were necessary because infections remain at a “high level, mainly in large cities.”

The announcement extends emergency measures imposed last month to two more prefectures, covering a total of six prefectures, including Tokyo and Osaka, that are together home to over a third of Japan’s 126 million people. Another eight prefectures will be under slightly looser restrictions.

The existing state of emergency, which were imposed to curb travel during the just-ended Golden Week holiday period and had been set to expire next week, have not slowed Japan’s fourth wave of coronavirus infections. In early March, the country recorded about 1,000 daily new. It is now recording nearly 6,000, according to a New York Times database.

Health officials say that they are seeing a growing number of cases of coronavirus variants spreading in the population, including at least 26 cases of the strain first detected in India. The authorities in Tokyo say that in four out of five cases found in the city, the infected person neither traveled abroad nor had close contact with someone who had.

The outbreak is stretching health care systems even in Japan’s biggest cities. On Thursday, there were 370 people being treated for serious cases of Covid-19 in Osaka, a prefecture of nine million people, more than the number of hospital beds available for seriously ill patients.

Japan, which has recorded more than 620,000 infections and 10,000 deaths since the start of the pandemic, has controlled the virus better than many countries. But the government has faced criticism for the sluggish pace of vaccinations, and for pledging to go ahead with the Tokyo Olympics, scheduled to begin on July 23, despite widespread public opposition.

Toru Hashimoto, a lawyer and a former governor of Osaka prefecture, said on a television show on Friday that Olympic organizers were ignoring the severity of Japan’s outbreak, and that it was inappropriate to continue holding pre-Olympic “test events” during the state of emergency, even though they are taking place without spectators.

“If the government wants to reduce the number of people in the city, it’s not a time when test events can be held,” Mr. Hashimoto said.

The government has imposed two previous states of emergency during the pandemic, although they are looser than the total lockdowns seen in many nations. The measures allow the prefectures to ask businesses to close or to restrict their hours, and to fine those that do not.

Under the extended state of emergency, people are asked not to go out for nonessential matters, especially after 8 p.m., and to refrain from traveling outside their prefectures. Karaoke parlors are asked to close, and restaurants requested not to serve alcohol, with fines of up to 300,000 yen, or $2,750, for noncompliance.

A vaccination center in Johannesburg in March.Credit…Joao Silva/The New York Times

A global debate is heating up over how to get Covid-19 vaccines to the nations most in need.

The United States supports an effort to suspend intellectual property protections on Covid-19 vaccines, and European countries say that richer nations should begin exporting more of their vaccine supply to poorer ones.

The European Union — whose approval is needed for any waiver of vaccine patents — said on Thursday that it would consider the Biden administration’s proposal. But Germany, the bloc’s largest economy, said that pushing pharmaceutical companies to share vaccine patents could have “significant implications” for the production of vaccines. The European Commission signaled it wouldn’t support the U.S. proposal.

“The limiting factor in vaccine manufacturing is production capacity and high-quality standards, not patents,” a spokeswoman for Chancellor Angela Merkel of Germany said in a statement.

Europe’s position emphasized the challenges of winning support for the waivers at the World Trade Organization, where the bloc wields significant influence, and where unanimous approval would be needed for any measure to suspend patents.

Many experts believe that the waivers are needed to expand the manufacturing of vaccines and get them to poorer parts of the world where inoculations have lagged behind those of richer countries.

Until the Biden administration’s announcement this week, the United States had been a major holdout at the W.T.O. over a proposal by India and South Africa to suspend some intellectual property protections. The move could give drugmakers access to the trade secrets of how the vaccines are made.

The pharmaceutical industry has argued that suspending patent protections would undermine risk-taking and innovation.

The debate arises amid a growing divide between wealthy nations that are slowly regaining normal life, and poorer countries that are confronting new and devastating outbreaks.

In India, which is suffering the world’s worst outbreak since the start of the pandemic, only 2.2 percent of the population is fully vaccinated, according to a New York Times database. South Africa has fully vaccinated less than 1 percent of its people. By contrast, vaccinations are slowing down in the United States — where one-third of people are fully inoculated — as they begin to pick up in Europe.

Even if a waiver receives support from the trade body, it alone would not increase the world’s vaccine supply. Large drug manufacturers in India and elsewhere would need extensive technological and other support to produce doses, experts say.

The American jobs engine slowed markedly last month, confounding rosy forecasts of the pace of the recovery and sharpening debates over how best to revive a labor market that was severely weakened by the coronavirus pandemic.

Employers added 266,000 jobs in April, the government reported Friday, far below the vigorous gains registered in March. The jobless rate rose slightly to 6.1 percent, as more people rejoined the labor force.

5

10

15%

’06

’08

’10

’12

’14

’16

’18

’20

“It turns out it’s easier to put an economy into a coma than wake it up,” Diane Swonk, chief economist for the accounting firm Grant Thornton, said of the disappointing report. “It’s understandable, it’s going to take some time, you’re not just going to snap your fingers and get everyone back to work,

Economists had forecast an addition of about a million jobs. The increase for March was revised down to 770,000 from 916,000.

The Alliance for American Manufacturing blamed supply chain problems for the loss of 18,000 jobs in that sector, noting in particular the impact that a shortage of semiconductors has had on the automotive industry.

And many offices are not yet ready to reopen fully. “I just think it takes a while for businesses to figure out how many people they need,” Ms. Swonk said, noting there is still a lot of skittishness on the part of employers and workers. “I don’t view this as terribly troubling or distressing.”

Ben Herzon, executive director of U.S. economics at the financial services company IHS Markit, agreed. “A single report with unexpected weakness in job gains is not a cause for concern,” he said. “Demand is picking up, activity is picking up.”

He noted that labor force participation had been on the upswing for two months in a row, rising to 61.7 percent last month from 61.4 percent in February.

More opportunities are bubbling up as coronavirus infections ebb, vaccinations spread, restrictions lift and businesses reopen. Job postings on the online job site Indeed are 24 percent higher than they were in February last year.

“There’s been a broad-based pickup in demand,” said Nick Bunker, who leads North American economic research at the Indeed Hiring Lab. The supercharged housing market is driving demand for construction workers. There is also an abundance of loading, stocking and other warehousing jobs — a side-effect of the boom in e-commerce.

The economy still has a lot of ground to regain before returning to prepandemic levels. Millions of jobs have vanished since February 2020, and the labor force has shrunk.

–20

–15

–10

–5 million

–8.2 million since February 2020

152.5 million jobs in February 2020

As the economy fitfully recovers, there are divergent accounts of what’s going on in the labor market. Employers, particularly in the restaurant and hospitality industry, have reported scant response to help-wanted ads. Several have blamed what they call overly generous government jobless benefits, including a temporary $300-a-week federal stipend that was part of an emergency pandemic relief program.

But there are other forces constraining the return to work. Millions of Americans have said that health concerns and child care responsibilities — with many schools and day care centers not back to normal operations — have prevented them from returning to work. Millions of others who are not actively job hunting are considered on temporary layoff and expect to be hired back by their previous employers once more businesses reopen fully. At the same time, some baby boomers have retired or switched to working part time.

An 18-year-old student received a shot of a coronavirus vaccine in Los Angeles last month.Credit…Etienne Laurent/EPA, via Shutterstock

A series of vaccine developments and the loosening of restrictions amid an improving virus trajectory may foreshadow a welcome return to normalcy for many young Americans, just as summer vacation nears.

By early next week, the Food and Drug Administration is expected to issue an emergency use authorization allowing the Pfizer-BioNTech coronavirus vaccine to be used in children 12 to 15 years old, a major step ahead in the United States’ efforts to tackle Covid-19. Pfizer also expects to seek federal clearance in September to administer the vaccine to children age 2 to 11, the company said on Tuesday.

Vaccinating children is key to raising the level of immunity in the population, experts say, and to bringing down the numbers of hospitalizations and deaths. It could also put school administrators, teachers and parents at ease if millions of adolescent students become eligible for vaccination before the next academic year begins.

The move would be a major leap forward, experts say, and comes as the director of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky, said that vaccinated adolescents would be able to remove their masks outdoors at summer camps.

Yet the eagerness of parents to let their children be vaccinated is limited, according to a new national poll, which found that three in 10 parents surveyed said they would get their children vaccinated right away and 26 percent said they wanted to wait to see how the vaccine was working. About 23 percent said they would definitely not get their children vaccinated, and 18 percent said they would do so only if a child’s school required it. The survey also noted that only 9 percent of respondents said they had not yet gotten a shot but still intended to do so, one more indication that achieving widespread immunity in the United States is becoming increasingly challenging.

As health experts focus on the future of vaccinating children, a growing number of students have returned to in-person learning this school year. In March, 54 percent of K-8 schools were open for full-time in-person learning, and 88 percent were open for either full-time in-person and/or hybrid learning, according to data from a federal government survey released on Thursday. But Black, Hispanic and Asian students are enrolled in full-time in-person learning at much lower rates than white students.

The Biden administration has made an aggressive push for reopening schools in recent months, including an effort to prioritize vaccinations for teachers and employees.

An airplane landing at the airport in Frankfurt, Germany.Credit…Michael Probst/Associated Press

One returning pilot lost control of an aircraft during landing and skidded off the runway into a ditch. Another just returning from furlough forgot to activate a critical anti-icing system designed to prevent hazards in cold weather. Several others flew at the wrong altitudes, which they attributed to distractions and lapses in communication.

In all of these incidents, which were recorded on NASA’s Aviation Safety Reporting System, a database of commercial aviation mistakes that are anonymously reported by pilots and other airline crew, the pilots involved blamed the same thing for their mistakes: a lack of practice flying during the pandemic.

In 2020, global air passenger traffic experienced the largest year-on-year decline in aviation history, falling 65.9 percent compared with 2019, according to the International Air Transport Association. Flights were grounded, schedules reduced and thousands of pilots were laid off or put on furlough for up to 12 months.

As vaccination programs pick up speed across some parts of the world and travel starts to rebound, airlines are beginning to reactivate their fleets and summoning pilots back as they prepare to expand their schedules for the summer. But returning pilots can’t just pick up where they left off.

“It’s not quite like riding a bike,” said Joe Townshend, a former pilot for Titan Airways, a British charter airline, who was laid off when the pandemic hit in March last year.

“You can probably go 10 years without flying a plane and still get it off the ground,” he said, “but what fades is the operational side of things.”

Marc Johnson, a virologist at the University of Missouri, examining samples of wastewater to track the coronavirus.Credit…MichaelB Thomas for The New York Times

Although Covid-19 is primarily a respiratory disease, research conducted early in the pandemic revealed that people infected with the coronavirus often shed it in their stool. This finding, combined with the scale and urgency of the crisis, spurred immediate interest in tracking the virus by sampling wastewater.

In the past year, many scientists have been drawn into the once niche field of wastewater epidemiology. Researchers in 54 countries are tracking the coronavirus in sewage, according to the Covid19Poops Dashboard, a global directory of the projects.

These teams have found that the wastewater data seemed to accurately indicate what was happening in society. When the number of diagnosed Covid-19 cases in an area increased, more coronavirus appeared in the wastewater. Levels of the virus fell when areas instituted lockdowns and surged when they reopened.

Several teams have also confirmed that sewage can serve as an early warning system: Wastewater viral levels often peaked days before doctors saw a peak in official Covid-19 cases.

And wastewater analysis has allowed scientists to detect the arrival of certain variants in a region weeks before they are found in people — and to identify mutations that have not yet been detected in people anywhere.

The surveillance is not a replacement for clinical testing, experts said, but can be an efficient and cost-effective complement. The approach is likely to be especially valuable in low- and middle-income countries, where testing resources are more limited.

“Not every population gets tested, not everyone has access to health care,” said Dr. Marc Johnson, a virologist at the University of Missouri. “If there’s groups of people that are asymptomatic, they probably aren’t getting tested either. So you aren’t really getting the full big picture. Whereas for our testing, everyone poops.”

global roundup

Administering the AstraZeneca vaccine in Nottingham, England, last month.Credit…Oli Scarff/Agence France-Presse — Getty Images

Britain’s vaccines regulator advised on Friday that all adults under 40 in the country should be offered alternatives to AstraZeneca’s Covid-19 vaccine. It factored in concerns over very rare blood clots, the dwindling risk of severe coronavirus infection in younger adults and the availability of alternatives.

The guidance extends earlier advice that people under 30 would be offered alternative doses.

The use of the AstraZeneca vaccine has been marred by uncertainty after reports of a possible link between the doses and very rare blood clots, but public health experts around the world say that the vaccine’s benefits far outweigh the risks for most people.

Britain’s Joint Committee on Vaccination and Immunization stressed that the chances of younger people becoming seriously ill with the coronavirus had grown smaller as infection rates decrease across the country. It said that this new reality paired with the availability of alternative vaccines had factored into the decision.

In other news from around the world:

  • Australia will resume repatriation flights for Australian nationals in India after May 15, Prime Minister Scott Morrison said on Friday. The resumption will end a travel ban that made it a criminal offense for citizens and residents of Australia to enter the country from India. No other democratic nation has issued a similar ban on all arrivals.

  • Tunisia will enter a weeklong nationwide lockdown starting on Sunday, Prime Minister Hichem Mechichi said on Friday. The country of nearly 12 million people has reported 11,122 deaths and 315,000 cases, according a New York Times database.

Categories
Business

Well being Advocate or Huge Brother? Firms Weigh Requiring Vaccines.

As American companies prepare to bring large numbers of workers back to the office in the coming months, executives face one of their most sensitive decisions related to pandemics: should they require employees to be vaccinated?

Take the case of United Airlines. In January, CEO Scott Kirby announced in a company town hall that he would require all of its 96,000 or so employees to receive coronavirus vaccines as soon as they are widely available.

“I think it’s the right thing,” Kirby said before asking other companies to follow suit.

It’s been four months. No major airline has made a similar promise – and United Airlines is waffling.

“It’s still something we think about, but no final decisions have been made,” said a spokeswoman, Leslie Scott.

For the largest companies in the country, mandatory vaccinations would protect service workers and reduce fear of office workers returning. This includes those who have been vaccinated but may be reluctant to return without knowing if their colleagues did too. And there is an element of the civil service: the herd immunity target has fallen as the pace of vaccinations has slowed.

However, the mandatory vaccination could spell a backlash and possibly even litigation for those who see it as an invasion of privacy and a Big Brother-like move to control the lives of employees.

In surveys, executives show willingness to request vaccinations. In a survey of 1,339 employers conducted by Arizona State University’s College of Health Solutions and funded by the Rockefeller Foundation, 44 percent of US respondents said they wanted to require vaccinations for their companies. In a separate survey of 446 employers conducted by Willis Towers Watson, a risk management company, 23 percent of respondents said they “plan or consider having employees vaccinated before they can return to the job site.”

That discrepancy, said Mara Aspinall, who led the survey in the state of Arizona, may have to do with the timing of the surveys and the pace at which executives are comfortable with the vaccines. The State of Arizona conducted its survey in March, while Willis Towers conducted the survey between February 23 and March 12.

Despite the surveys, few executives have taken the step to prescribe vaccines. It seems that most hope that encouragement, whether powerful or subtle, will be enough.

“While legally in the United States, employers can prescribe vaccines while providing shelter for religious and health reasons. This is much more difficult socially in terms of social acceptance of these decisions,” said Laura Boudreau, professor of public policy at the University from Columbia. “And so the reputational risks for these companies, if they get it wrong, are really high.”

Douglas Brayley, an employment law attorney at global law firm Ropes & Gray, warns clients of the implications of fulfilling a mandate, he said.

“What if 10 percent of your workforce refuses? Are you ready to lay off that 10 percent? “He said he asked customers. “Or what if it was someone at a high level or in a key role, would you be willing to impose consequences? And then sometimes they get more nervous. “

He added, “Anytime they mandate but then implement the consequences unevenly, they run the risk of potentially unlawful, unfair treatment.”

Updated

May 6, 2021, 7:57 p.m. ET

Companies in need of vaccines may also be concerned about side effects or medical issues that an employee claims were caused by the vaccine.

“You could be held liable for any kind of adverse effects that might occur a year or two later,” said Karl Minges, chairman of health administration and policy at the University of New Haven.

Some companies work around the problem and try incentives instead. Amtrak pays employees a regular wage of two hours per shot after proof of vaccination. Darden, which owns Olive Garden and other restaurants, told staff that they would offer hourly staff two hours of wages for every dose they received, stressing that it would not make mandatory doses mandatory. Target is offering a $ 5 voucher to all customers and employees who receive their vaccination at a CVS at the Target location.

In the United States, the need for vaccines for participation in public life is nothing new. The Supreme Court ruled about a century ago that states could require vaccinations for children attending public schools. And universities like Rutgers have introduced mandatory Covid-19 vaccinations.

However, the pandemic brings with it a number of complications that companies typically prefer to avoid, including personal life, religious preferences, and employee medical history, such as: For example, if an employee is pregnant, breastfeeding, or immunocompromised, information they may not want to reveal.

Large union groups such as the AFL-CIO have also not aggressively promoted the issue. They face dueling forces – on the one hand they stand up for the rights of the individual employees and on the other hand protect each other. The unions have also spoken out in favor of stricter safety measures in the workplace. These efforts could be hampered by companies’ reasoning that compulsory vaccinations reduce the need for such shelters. For example, the return to work protocols negotiated between the Alliance of Motion Picture & Television Producers and Hollywood’s unions do not include mandatory vaccinations.

“There will be some people who have valid reasons for not getting the vaccine or wanting to talk about it,” said Carrie Altieri, who works in communications for the IBM People and Culture business. “It’s not an easy problem at this point.” IBM is working with New York State on a digital passport that links a person’s vaccination records to an app to display businesses, such as venues, that may require vaccination. However, no vaccinations are required for employees.

For some businesses, such as restaurants, that are already struggling to recruit, the vaccination requirement could make it even more difficult to hire. And there are questions of logistics and execution. How can companies confirm the veracity of those who say they have been vaccinated?

Businesses may need to hire additional staff, possibly with medical training, to perform tasks that could cost businesses – especially small ones – high costs.

Vivint, a Utah-based home security company with 10,000 employees, began offering vaccines at its on-site clinic this week after the state approved the company to distribute 100 shots a week to its employees. It paid $ 3,000 for the necessary medical freezer.

“We don’t require employees to be vaccinated, but we encourage them very much,” said Starr Fowler, senior vice president of human resources. “For many of our employees, especially younger ones, the easier we make it for them, the more likely they will do it.”

Others experiment with the division of their labor force. Salesforce is rolling out a policy in certain US offices, including the Salesforce Tower in San Francisco, where up to 100 fully vaccinated employees can volunteer to work on specific floors. The New York Stock Exchange issued a memo to trading firms saying they could increase their staff on the floor, provided all staff were vaccinated.

The Equal Employment Opportunity Commission issued guidelines in December stating that employers were actually legally allowed to require workers to be vaccinated before returning to work. However, there is still a risk of litigation.

“Concerning the possibility of litigation seems to me a perfectly legitimate concern,” said Eric Feldman, a law professor at the University of Pennsylvania. He added, “It seems to me that employers will be in a pretty strong position legally – but that doesn’t mean they won’t be sued.”

According to the National Conference of State Legislatures, legislation has been proposed in at least 25 states that would limit the ability to require vaccines for students, employees, or the public in general. Some of these restrictions only affect vaccines that, like those for Covid-19, have not yet been fully approved by the Food and Drug Administration. (The coronavirus vaccines have been approved for emergencies with reservations.)

Pfizer is expected to file for full approval of its Covid-19 vaccine soon. Others are likely to follow.

Jamie Dimon, the executive director of JPMorgan Chase, spoke at a conference in the Wall Street Journal this week on “legal issues with obtaining vaccines” when asked if he would like to get workers back into the office. A spokesman for the bank, which plans to open its offices on May 17 on a voluntary basis, said it had strongly recommended vaccines for employees – apart from religious or health restrictions – but would not need them. A Goldman Sachs spokeswoman, who did not lead the staff one way or another, declined to comment.

One possible avenue for companies looking for a middle ground is to only award the shots to new hires. Even so, there is a fine line between encouraging and requiring the gunshot – which sometimes leads to conflicting messages to employees.

Investment bank Jefferies sent a memo to employees in early February stating, “Vaccination verification is required to access the office.” A follow-up memo was issued on February 24th. “We didn’t want it to sound like we were prescribing vaccines,” it said.

Coverage was contributed by Rebecca Robbins, Sapna Maheshwari, Kellen Browning, Niraj Chokshi and Eshe Nelson.